Studies have shown that active fund managers routinely underperform the S&P500 index*​

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO)

AGIO Stock Predictions and Ratings

WSX Rating:
STRONG BUY
WSX Forecast (1yr):
87.90%
Analyst Rating:
BUY
Analyst Forecast (1yr):
38.20%

AGIO Stock Analysis

AGIO PE Ratio:

AGIO PEG Ratio: Not Available

AGIO Forward EPS Growth (12 month): 0.00%

AGIO PS Ratio: 24.9

AGIO PSG Ratio: 0.2

AGIO Forward Revenue Growth (12 month): 109.20%